04/29
Headlines

NASDAQ:ZGNX

Stocks to Watch : Zogenix, Inc. (NASDAQ:ZGNX), Morgan Stanley (NYSE:MS), China Biologic Products, Inc. (NASDAQ:CBPO), Resonant Inc. (NASDAQ:RESN), Arbor Realty Trust Inc. (NYSE:ABR)

Chris Lewis03 mins

Zogenix Inc. (NASDAQ: ZGNX) has submitted its supplemental new drug application (sNDA) with the U.S. Food and Drug Administration, we have seen some analyst commentary that is worth noting. Oppenheimer’s Akiva Felt and Angad Verma have issued their report. The official rating remains as Outperform, but what stands out here is that the $2.50 price…

Read More

Trader’s Recap : Office Depot, Inc. (NASDAQ:ODP), Zogenix, Inc. (NASDAQ:ZGNX), Johnson & Johnson (NYSE:JNJ), Intel Corporation (NASDAQ:INTC), Verizon Communications Inc. (NYSE:VZ)

Colin Pettis02 mins

The 2013 merger of Office Depot, Inc. (NASDAQ:ODP) and OfficeMax means the end of one’s presence in Jackson. Office Depot, 1510 N. West Ave., will close Nov. 15. The location is advertising merchandise being 50 percent off as part of a “moving” sale. Office Depot, Inc. (NASDAQ:ODP) belongs to Services sector. Its net profit margin…

Read More

Healthcare Active Movers: Zogenix, Inc. (NASDAQ:ZGNX), Orexigen Therapeutics (NASDAQ:OREX), Merck & Co (NYSE:MRK), Boston Scientific Corporation (NYSE:BSX), Bristol-Myers Squibb (NYSE:BMY)

Richard Atkins03 mins

Zogenix, Inc (NASDAQ:ZGNX) CEO Roger Hawley unloaded 25,078 shares of the company’s stock on the open market in a transaction that occurred on Tuesday, June 3rd. The shares were sold at an average price of $2.10, for a total transaction of $52,663.80. Following the completion of the sale, the chief executive officer now directly owns…

Read More